What are the classifications of atrial fibrillation (AF)?

Atrial Fibrillation Classification Systems

Atrial fibrillation is classified using two complementary systems: a temporal classification (first-detected, paroxysmal, persistent, long-standing persistent, and permanent) and a newer stage-based classification (Stages 1-4) that emphasizes disease progression and prevention strategies. 1, 2

Temporal Classification System

The ACC/AHA/ESC consensus establishes five temporal categories based on episode duration and termination patterns 1, 2:

First-Detected AF

• Any initial presentation of AF, regardless of symptoms or duration 2
• May be either paroxysmal or persistent in nature 2
• Recognizes uncertainty about actual arrhythmia duration and possible previous undetected episodes 1

Paroxysmal AF

• Episodes that self-terminate spontaneously within 7 days, most commonly within 24 hours 1, 2, 3
• Individual episodes last seconds to hours but can recur repeatedly over years 2
• The critical distinction is spontaneous termination without intervention 2

Persistent AF

• Episodes sustained beyond 7 days 1, 2, 3
• Termination with pharmacological therapy or direct-current cardioversion does not change this designation 1, 2
• Can represent either first presentation or culmination of recurrent paroxysmal episodes 1

Long-Standing Persistent AF

• AF present for greater than 1 year 1, 2, 3
• Typically represents progression toward permanent AF 2
• Usually indicates cases where cardioversion has failed or has not been attempted 1, 2

Permanent AF

• Cardioversion has failed or not been attempted, with both patient and physician accepting the arrhythmia as the ongoing rhythm 1, 2, 3
• This definition is often arbitrary and represents a clinical decision rather than a specific temporal threshold 2
• The designation can be changed if rhythm control is subsequently pursued 1

Stage-Based Classification System (2023 ACC/AHA/ACCP/HRS)

The 2023 guidelines introduced a disease continuum model that emphasizes prevention and progression 1, 3:

Stage 1: At Risk for AF

• Patients with AF-associated risk factors without documented AF 1, 3
• Includes obesity, hypertension, and other modifiable risk factors 3

Stage 2: Pre-AF

• Evidence of structural or electrical findings predisposing to AF without documented AF episodes 1, 3
• Signs of atrial pathology on electrocardiogram or imaging 3

Stage 3: AF Present

• Includes paroxysmal, persistent, long-standing persistent AF, and patients with successful AF ablation 1, 3
• Represents clinically manifest disease requiring active management 1

Stage 4: Permanent AF

• Permanent AF as defined in temporal classification 1
• Represents end-stage disease where rhythm control is no longer pursued 1

Important Clinical Distinctions

Secondary AF

• AF occurring in the context of acute MI, cardiac surgery, pericarditis, myocarditis, hyperthyroidism, pulmonary embolism, or pneumonia should be considered separately 1, 2
• Treating the underlying condition typically terminates the arrhythmia without recurrence 2
• This distinction is critical as it affects long-term management decisions 1

Lone AF

• Applied to young individuals (aged less than 60 years) without clinical or echocardiographic evidence of cardiopulmonary disease 1
• These patients have a favorable prognosis regarding thromboembolism and mortality 1
• Patients move out of this category over time with aging or development of cardiac abnormalities 1

Nonvalvular AF

• Restricted to cases occurring in the absence of rheumatic mitral stenosis or prosthetic heart valve 1
• This distinction is important for anticoagulation decisions 1

Critical Clinical Caveats

• Categories are not mutually exclusive in individual patients—the same patient may experience both paroxysmal and persistent episodes at different times 2
• Patients should be categorized by their most frequent presentation pattern 2
• Recurrent AF is defined as having 2 or more episodes, which can be either paroxysmal or persistent 1, 2
• The stage-based system recognizes that lifestyle and risk factor modification should be emphasized throughout the entire disease continuum 1